NOTCH2NLC mutation-positive neuronal intranuclear inclusion disease with retinal dystrophy: A case report and literature review.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
12 May 2023
Historique:
medline: 15 5 2023
pubmed: 12 5 2023
entrez: 12 5 2023
Statut: ppublish

Résumé

Neuronal intranuclear inclusion disease (NIID) is a neurodegenerative disorder that produces a broad spectrum of clinical conditions such as dementia, upper motor neuron involvement, extrapyramidal symptoms, and neuropathy. Some studies have reported ophthalmological conditions associated with the disease; however, the details of these conditions remain unclear. We report a 63-year-old Japanese female with cognitive decline, blurred vision, photophobia, and color blindness at 52 years of age who was diagnosed with cone dystrophy. She also had anxiety, insomnia, depression, delusions, hallucinations, a wide-based gait with short steps, and urinary incontinence. Magnetic resonance imaging revealed diffuse cerebral white matter changes and subcortical hyperintensity on diffusion-weighted imaging. Skin biopsy showed p62-positive intranuclear inclusions in sweat glands. NOTCH2NLC gene analysis revealed abnormal GGC expansion; therefore, NIID was diagnosed. NOTCH2NLC mutation-positive NIID may be associated with retinal dystrophy. Brain magnetic resonance imaging and skin biopsy are helpful diagnostic clues, and gene analysis is crucial for accurate diagnosis and appropriate management.

Identifiants

pubmed: 37171294
doi: 10.1097/MD.0000000000033789
pii: 00005792-202305120-00001
pmc: PMC10174370
doi:

Types de publication

Review Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e33789

Informations de copyright

Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors have no funding and conflicts of interest to disclose.

Références

Neurol Sci. 2021 Oct;42(10):4055-4062
pubmed: 34333668
Handb Clin Neurol. 2018;147:105-123
pubmed: 29325606
Acta Neuropathol. 2013 Jul;126(1):1-19
pubmed: 23793382
Neurol Sci. 2022 May;43(5):3231-3237
pubmed: 34797461
J Formos Med Assoc. 2021 Sep;120(9):1793-1795
pubmed: 33858738
Neurology. 2011 Apr 19;76(16):1372-6
pubmed: 21411744
J Neurol Sci. 2018 May 15;388:84-86
pubmed: 29627037
Ophthalmic Genet. 2020 Feb;41(1):93-95
pubmed: 32039647
Invest Ophthalmol Vis Sci. 2020 Sep 1;61(11):27
pubmed: 32931575
Ann Clin Transl Neurol. 2020 Sep;7(9):1716-1725
pubmed: 32777174
Mol Neurobiol. 2022 Jan;59(1):523-534
pubmed: 34718964
Nat Genet. 2019 Aug;51(8):1215-1221
pubmed: 31332381

Auteurs

Takayuki Katayama (T)

Department of Neurology, Asahikawa City Hospital, Japan.

Kae Takahashi (K)

Department of Neurology, Asahikawa City Hospital, Japan.

Osamu Yahara (O)

Department of Neurology, Asahikawa City Hospital, Japan.

Jun Sawada (J)

Division of Neurology, First Department of Internal Medicine, Asahikawa Medical University, Japan.

Ken-Ichi Ishida (KI)

Division of Neurology, First Department of Internal Medicine, Asahikawa Medical University, Japan.

Asuka Asanome (A)

Division of Neurology, First Department of Internal Medicine, Asahikawa Medical University, Japan.

Hisako Endo (H)

Division of Neurology, First Department of Internal Medicine, Asahikawa Medical University, Japan.

Tsukasa Saito (T)

Division of Neurology, First Department of Internal Medicine, Asahikawa Medical University, Japan.

Naoyuki Hasebe (N)

Division of Neurology, First Department of Internal Medicine, Asahikawa Medical University, Japan.

Mari Kishibe (M)

Department of Dermatology, Asahikawa Medical University, Japan.

Harumi Kanno (H)

Department of Ophthalmology, Asahikawa City Hospital, Japan.

Satoshi Ishiko (S)

Department of Ophthalmology, Asahikawa Medical University, Japan.

Jun Sone (J)

Institute for Medical Science of Aging, Aichi Medical University, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH